The CSF biomarker-integrated reclassification significantly improved the distinction between subgroups regarding CAA- and arteriosclerosis-related MRI features and support a future transition toward an integrated biological-radiological framework, which may refine in vivo CAA diagnosis, particularly in mixed SVD.
M. Losa, M. C. Ramusino, I. Gandoglia et al.· medRxiv· 0 citations
It is demonstrated that anti-Aβ immunotherapy rapidly initiates a coordinated central and peripheral immune response at the leptomeningeal interface, which represents a plausible initiating mechanism for ARIA and provides a mechanistic framework to guide strategies for mitigating ARIA risk.
Key takeaways from the Fall 2025 AARR meeting are presented, which brought together academic, clinical, and industry leaders to discuss and explore the current advances in the heterogeneity and co‐pathologies of AD and their implications for diagnosis, clinical trial design, and precision treatment strategies.
M. Tansey, S. Bozeat, Peter Ackerman et al.· Alzheimer's & Dementia· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.